Biography and Research Information
OverviewAI-generated summary
Katherine B. Bosanko's research focuses on the genetic basis of neurodevelopmental disorders. Her work has investigated the role of specific gene variants, such as those in the *AGO1* and *SATB2* genes, in conditions like intellectual disability and SATB2-associated syndrome. Bosanko has studied the clinical manifestations of these syndromes across different age groups, including growth patterns, abnormalities in pharyngeal arch-derived structures, and bone health. Her research also explores the metabolic profiles and cellular energy alterations associated with SATB2-associated syndrome. Bosanko collaborates with researchers at the University of Arkansas for Medical Sciences, including Yuri A. Zárate, with whom she has co-authored 11 publications. Her scholarship metrics include an h-index of 3, with 3 total publications and 250 total citations.
Metrics
- h-index: 3
- Publications: 3
- Citations: 252
Selected Publications
-
P288: A review of phenotypic and genetic data in craniofacial microsomia cases from a multidisciplinary craniofacial clinic (2025)
-
Pathogenic <i>SATB2</i> missense variants affecting p.Gly392 have variable functional implications and result in diverse clinical phenotypes (2024)
-
Abnormalities in pharyngeal arch‐derived structures in SATB2‐associated syndrome (2024)
-
Bone health in <i>SATB2</i>‐associated syndrome: Results from a large prospective cohort and recommendations for surveillance (2023)
-
Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome (2023)
-
P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal (2023)
-
Growth in individuals with <i>SATB2</i>‐associated syndrome (2022)
-
<i>De novo</i> coding variants in the <i>AGO1</i> gene cause a neurodevelopmental disorder with intellectual disability (2021)
-
Case Report: SATB2-Associated Syndrome Overlapping With Clinical Mitochondrial Disease Presentation: Report of Two Cases (2021)
-
<scp><i>SATB2</i>‐associated</scp> syndrome in adolescents and adults (2021)
-
Individuals with SATB2-associated syndrome with and without autism have a recognizable metabolic profile and distinctive cellular energy metabolism alterations (2021)
-
Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving <i>SATB2</i> (2020)
-
<i>De novo</i> coding variants in the <i>AGO1</i> gene cause a neurodevelopmental disorder with intellectual disability (2020)
-
JARID2 haploinsufficiency is associated with a clinically distinct neurodevelopmental syndrome (2020)
-
Genetic counseling graduate training to address religion and spirituality in clinical practice: A qualitative exploration of programs in North America (2020)
Collaboration Network
Top Collaborators
- <scp><i>SATB2</i>‐associated</scp> syndrome in adolescents and adults
- Growth in individuals with <i>SATB2</i>‐associated syndrome
- Individuals with SATB2-associated syndrome with and without autism have a recognizable metabolic profile and distinctive cellular energy metabolism alterations
- Abnormalities in pharyngeal arch‐derived structures in SATB2‐associated syndrome
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
Showing 5 of 9 shared publications
- <scp><i>SATB2</i>‐associated</scp> syndrome in adolescents and adults
- Growth in individuals with <i>SATB2</i>‐associated syndrome
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Growth in individuals with <i>SATB2</i>‐associated syndrome
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Quantitative Phenotype Morbidity Description of SATB2-Associated Syndrome
- P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portal
- Abnormalities in pharyngeal arch‐derived structures in SATB2‐associated syndrome
- Bone health in <i>SATB2</i>‐associated syndrome: Results from a large prospective cohort and recommendations for surveillance
- Individuals with SATB2-associated syndrome with and without autism have a recognizable metabolic profile and distinctive cellular energy metabolism alterations
Similar Researchers
Based on overlapping research topics